NLM Logo

Gemtuzumab MeSH Descriptor Data 2023


MeSH Heading
Gemtuzumab
Tree Number(s)
D09.408.051.247.500
D12.776.124.486.485.114.224.060.790
D12.776.124.790.651.114.224.060.790
D12.776.377.715.548.114.224.200.790
Unique ID
D000079982
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000079982
Scope Note
Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.
Entry Term(s)
CMA 676
CMA-676
Gemtuzumab Ozogamicin
Gemtuzumab-Ozogamicin
Mylotarg
Pharm Action
Antineoplastic Agents, Immunological
Immunotoxins
Registry Number
93NS566KF7
Related Numbers
8GZG754X6M
Public MeSH Note
2020; GEMTUZUMAB was indexed under AMINOGLYCOSIDES and ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2019; and under ANTIBODIES, MONOCLONAL 2000-2011
History Note
2020 (2000)
Date Established
2020/01/01
Date of Entry
2019/07/08
Revision Date
2019/04/29
Gemtuzumab Preferred
Mylotarg Narrower
Gemtuzumab Ozogamicin Narrower
CMA 676 Narrower
page delivered in 0.251s